Document Detail


A secondary progressive clinical course is uncommon in neuromyelitis optica.
MedLine Citation:
PMID:  17310032     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We compared the clinical course of 96 patients with neuromyelitis optica (NMO) to multiple sclerosis (MS) natural history data. Based on the distribution of follow-up data (median 6.1 year), we estimated that 21 NMO patients would convert to a secondary progressive course, but we observed only two conversions (p = 0.00002; relative risk = 0.08). The disparate natural histories of MS and NMO suggest dissociation between relapses and clinical progression in CNS demyelinating diseases.
Authors:
D M Wingerchuk; S J Pittock; C F Lucchinetti; V A Lennon; B G Weinshenker
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Neurology     Volume:  68     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-20     Completed Date:  2007-03-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  603-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, Mayo Clinic College of Medicine, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. wingerchuk.dean@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cohort Studies
Disease Progression
Female
Humans
Incidence
Male
Middle Aged
Multiple Sclerosis, Chronic Progressive / epidemiology*,  physiopathology*
Muscle Weakness / epidemiology,  physiopathology
Muscle, Skeletal / innervation,  physiopathology
Neuromyelitis Optica / epidemiology*,  physiopathology*
Optic Nerve / immunology,  pathology,  physiopathology
Recurrence
Vision, Low / epidemiology,  physiopathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of referral bias on assessing survival in ALS.
Next Document:  Lacunar infarct or deep intracerebral hemorrhage: who gets which? The Northern Manhattan Study.